Sep 2026· Journal of Ayurveda and Integrated Medical Sciences· 0 citations· 7 references
TL;DR
A case of a 20 year-old female with a 2-year history of irregular menses and an obesity issue and a proper, customized ayurvedic treatment for PMOS, which showed normalization in ovarian size and no signs of peripheral follicles, indicating an improvement in PMOS.
Abstract
Polyendocrine Metabolic Ovarian Syndrome (PMOS) is a prevalent endocrine-metabolic disorder in reproductive age with an estimated global increasing rate ranging from 10-15% due to modern lifestyle changes. The term PMOS emphasizes the multisystem endocrine, metabolic, and ovarian dimensions of the condition rather than implying that true ovarian cysts are the defining feature. In this case study, we are presenting a case of a 20 year-old female with a 2-year history of irregular menses and an obesity issue (25% rise from normal weight). The ultrasound revealed bulky ovaries with echogenic stroma and a few peripherally placed follicles. The patient underwent a proper, customized ayurvedic treatment, including internal medicine, Yogabasti, diet, lifestyle modification, and Yoga. Over a period of nine months, the ultrasound scan report showed normalization in ovarian size and no signs of peripheral follicles, indicating an improvement in PMOS. Additionally, the patient experienced considerable improvement, including regular menstrual cycles and a normal weight (reducing from 70kg to 56kg). This individualized Ayurvedic approach highlights the potential effectiveness of Ayurvedic management for PMOS.
Recognizing PMOS as an early-life marker of cardiometabolic disease highlights opportunities for earlier diagnosis, prevention, and individualized risk stratification, supporting integrated, patient-centered care across the life course.
M. Forslund, J. Melin, A. Joham et al.· Journal of Internal Medicine· 0 citations
Polycystic ovary syndrome (PCOS) is one of the most prevalent endocrine and metabolic disorders among women of reproductive age. Evolving diagnostic criteria—from the initial Stein–Leventhal report through the National Institutes of Health (NIH), Rotterdam, and Androgen Excess and PCOS Society (AE PCOS) frameworks, alo...
Mina Amiri, N. Panahi, M. Amoli et al.· Iranian Journal of Diabetes...· 0 citations
Dealing with PMOS is challenging since normal pubertal development overlaps typical features of syndrome, and healthcare providers should make the diagnosis of PMOS on evidence-based guidelines to prevent delayed, under diagnosis or over diagnosis.
Neeti Gupta, M. Agrawal, Suchismita Das· International Journal of Rep...· 0 citations
Polycystic Ovary Syndrome (PCOS) is one of the most common endocrine and metabolic disorders among women of reproductive age worldwide, with an estimated global prevalence of 8-13% depending on the diagnostic criteria used. The term Polycystic Ovary Syndrome is a common clinical finding, but has been increasingly criti...
Mahi Killekar· International Journal of Adv...· 0 citations
Polyendocrine metabolic ovarian syndrome (PMOS) is one of the most common endocrine conditions affecting hundreds of millions of women globally. The former name polycystic ovary syndrome (PCOS) was inaccurate, underpinning the robust nomenclature change process. This review historically traces renaming efforts up to, i...
H. Teede, Saeede Saadati, Rachel Morman et al.· Fertility and Sterility· 0 citations
Background: PMOS is most common hormonal disorder in females of reproductive age group. In PMOS many pearl sized cysts are formed in the ovaries. These cysts contain immature eggs. High LH, low FSH, high Testosterone in PMOS causes changes in physical appearance, irregularity in menstrual cycle and if not treated in ti...
Vani Bansal, Palak Meena, Kunal Bansal et al.· International Journal of Res...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.